The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis:results of a phase II study
| Data(s) |
01/05/2007
|
|---|---|
| Resumo |
This study was designed to assess the potential of the continuous erythropoietin receptor activator (C.E.R.A.) to correct anemia at extended administration intervals in erythropoiesis-stimulating agent-naīve patients with chronic kidney disease (CKD) not on dialysis and to determine its optimal starting dose. |
| Identificador | |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Provenzano , R , Besarab , A , Macdougall , I C , Ellison , D H , Maxwell , A P , Sulowicz , W , Klinger , M , Rutkowski , B , Correa-Rotter , R , Dougherty , F C & BA 16528 Study Investigators 2007 , ' The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis : results of a phase II study ' Clinical nephrology , vol 67 , no. 5 , pp. 306-17 . |
| Palavras-Chave | #Adult #Aged #Aged, 80 and over #Analysis of Variance #Anemia #Area Under Curve #Biological Markers #Dose-Response Relationship, Drug #Erythropoiesis #Erythropoietin #Female #Ferritins #Follow-Up Studies #Hemoglobins #Humans #Kidney Failure, Chronic #Male #Middle Aged #Polyethylene Glycols #Recombinant Proteins #Regression Analysis #Renal Dialysis #Time Factors #Treatment Outcome |
| Tipo |
article |
